We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Biocartis Announces the End of its Alliance with bioMérieux
News

Biocartis Announces the End of its Alliance with bioMérieux

Biocartis Announces the End of its Alliance with bioMérieux
News

Biocartis Announces the End of its Alliance with bioMérieux

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Biocartis Announces the End of its Alliance with bioMérieux"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Biocartis has announced that bioMérieux and Biocartis have signed an agreement to end their alliance for the development and commercialization of the integrated molecular biology system, Idylla™ (previously Apollo), in the field of microbiology molecular diagnostics. bioMérieux will return all rights on the Idylla™ platform to Biocartis.

In November 2010, Biocartis had entered into a strategic alliance with bioMérieux to develop and commercialize microbiology assays on Biocartis’ fully integrated molecular diagnostics platform Idylla™.

With the ending of the alliance, Biocartis has regained all the rights relating to the use of its platform in the microbiology field, and is free to explore new strategic options in that respect.

Rudi Pauwels, CEO of Biocartis, commented: “We will definitely keep microbiology assays in the menu of tests on the Idylla™ platform, either through internal developments or via a new partner.”

Advertisement